Northwire Canada EditionFriday, October 16, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8% GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8%

Healthcare

Page 33
  1. Apr 16, 2026 · 05:48 · 4568

    Daiichi Sankyo Partnership Validates MNM Platform but Financial Terms Remain Opaque

    Interna Therapeutics Announces Research Collaboration with Daiichi Sankyo to Advance MNM-Based Targeted Delivery Technologies

    01
  2. Apr 15, 2026 · 17:31 · MDP

    Medexus Confirms Cash Flow Accretion as GRAFAPEX Commercialization Accelerates

    Medexus Provides Business Update on GRAFAPEX (treosulfan) for Injection, Capital Allocation, and Investor Conference Participation

    02
  3. Apr 15, 2026 · 17:30 · COV

    Covalon Stabilizes Post-Dividend with Operational Momentum Despite Revenue Contraction

    Covalon Technologies Reports Significant Milestones Spanning Vascular Access, Infection Prevention, and Wound Care

    03
  4. Apr 15, 2026 · 08:02 · BPC

    Management Spending on Marketing and Advisory Signals Operational Expansion Without Immediate Revenue Catalyst

    The Precision Peptide Company Announces Public Relations and Consulting Services Agreement

    04
  5. Apr 15, 2026 · 08:00 · MVMD

    MVMD Closes Financing to Fuel Agrarius Commercialization Amid Dilutive Share Issuance

    Mountain Valley MD Announces Closing of Non-Brokered Private Placement of Units and Concurrent Shares for Debt Transactions

    05
  6. Apr 15, 2026 · 07:01 · FNDX

    FendX Pivots Manufacturing Strategy Amidst Partnership Exit

    FendX Engages Galenvs for Pilot Scale-Up Manufacturing of Its Liquid Surface Coating

    06
  7. Apr 15, 2026 · 07:00 · MBX

    Microbix Biosystems Showcases HCV Mimetic as Revenue Contracts Shrink and Cash Burn Accelerates

    Microbix Exhibiting & Presenting at ESCMID Global 2026

    07
  8. Apr 15, 2026 · 04:40 · 4174

    Advancing Glycan-based ADC Technology

    OBI Pharma Announces Ten Poster Presentations at the AACR 2026 Annual Meeting for GlycOBI(R) Glycan-based Site-Specific Antibody-Drug Conjugates (ADCs): Mono and Bi-Specific (inc. Dual payload) and Obrion(TM) ADC enabling technologies

    08
  9. Apr 14, 2026 · 19:59 · OPEN

    SPAC Merger Finalized Amidst Significant Valuation Compression

    Opensesame signs definitive agreement to acquire Vector

    09
  10. Apr 14, 2026 · 18:45 · IOT

    Innovotech Expands U.S. Access Following Profitable FY25 Turnaround

    Innovotech Inc. Begins Trading on OTCQB Under Symbol IOTCF, Expanding Access for U.S. Investors

    10
  11. Apr 14, 2026 · 17:35 · CYTO

    Cytophage Sheds COO as Cash Burn Forces Strategic Review

    Cytophage Announces Departure of Chief Operating Officer

    11
  12. Apr 14, 2026 · 14:20 · OTC

    Clinical Momentum Sustains Amidst Financing Constraints and Debt Restructuring

    Ocumetics Technology Reports Attendance at ASCRS as Successful First-In-Human Trial Continues, No Material Change

    12
  13. Apr 14, 2026 · 09:51 · SEGN

    Certification Milestone Validates Platform Maturity But Revenue Visibility Remains Constrained

    Seegnal Inc. Receives Gold Mark from the Standards Institution of Israel, Advancing Commercialization Readiness

    13
  14. Apr 14, 2026 · 09:45 · NARA

    Tagline: PanGenomic Shareholders Face 85% Dilution in Ayla BioScience Takeover Bid

    PanGenomic Health Announces Letter of Intent with Ayla BioScience

    14
← Newer Older →